Medindia

X

Isolagen to Present at the Morgan Stanley Global Healthcare Unplugged Conference

Saturday, April 26, 2008 General News J E 4
Advertisement
EXTON, Pa., April 25 Isolagen(TM), Inc.(Amex: ILE) today announced that the Company will participate in the MorganStanley Global Healthcare Unplugged Conference on Thursday, May 1, 2008 at3:40 p.m. EDT. The conference is being held April 30 - May 2, 2008 at theRitz-Carlton Key Biscayne in Key Biscayne, Florida.

The session will be webcast live and the audio can be accessed by visitinghttp://www.isolagen.com . An archive will be available there for 30 daysfollowing the conference.

About Isolagen, Inc.

Isolagen(TM), Inc. (Amex: ILE) is an aesthetic and therapeutic companycommitted to developing and commercializing scientific advances and innovativetechnologies. The company's technology platform includes the IsolagenProcess(TM), a cell processing system for skin and tissue rejuvenation whichis currently in clinical development for a broad range of aesthetic andtherapeutic applications including wrinkles, acne scars, burns and periodontaldisease. Isolagen also commercializes a scientifically-advanced line ofskincare systems through its majority-owned subsidiary, Agera(R) Laboratories,Inc. For additional information, please visit http://www.isolagen.com .

Isolagen Forward Looking Statements

All statements in this news release that are not based on historical factare "forward-looking statements" within the meaning of the Private SecuritiesLitigation Reform Act of 1995 and the provisions of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. While management has based any forward-lookingstatements contained herein on its current expectations, the information onwhich such expectations were based may change. These forward-lookingstatements rely on a number of assumptions concerning future events and aresubject to a number of risks, uncertainties, and other factors, many of whichare outside of our control, that could cause actual results to materiallydiffer from such statements. Such risks, uncertainties, and other factorsinclude, but are not necessarily limited to, those set forth under Item 1A"Risk Factors" in the Company's Annual Report on Form 10-K for the year endedDecember 31, 2007, as updated in "Item 1A. Risk Factors" in the Company'sQuarterly Reports on Form 10-Q. We operate in a highly competitive and rapidlychanging environment, thus new or unforeseen risks may arise. Accordingly,investors should not place any reliance on forward-looking statements as aprediction of actual results. We disclaim any intention to, and undertake noobligation to, update or revise any forward-looking statements. Readers arealso urged to carefully review and consider the other various disclosures inthe Company's Annual Report on Form 10-K for the year ended December 31, 2007,as well as other public filings with the SEC since such date.

SOURCE Isolagen, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
/C O R R E C T I O N -- Concerned Dog Owners of Ca...
S
Update: Delcath Expands Phase III Trial for Metast...